Linked Data API

Show Search Form

Search Results

982661
registered interest false more like this
date less than 2018-10-08more like thismore than 2018-10-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many blood cancer patients have received medicine funded by the Cancer Drugs Fund by each medicine since 2016. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 176228 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2018-10-16
answer text <p>We have been informed by NHS England that since the implementation of the new Cancer Drugs Fund on 29 July 2016, 7,821 patients have been registered to receive treatment for a blood cancer, out of a total of approximately 25,700 patients who have been registered to receive cancer drug treatment. NHS England has advised that it is unable to provide a breakdown of patients registered to receive treatment with each medicine for reasons of commercial confidentiality.</p> more like this
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
question first answered
less than 2018-10-16T16:10:46.937Zmore like thismore than 2018-10-16T16:10:46.937Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917376
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people with blood cancer that will be referred into the Improving Access to Psychological Therapies integrated pathway as a result of the NHS Digital pilot data, published on 10 May 2018. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150002 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>NHS England has not specified estimates of individual conditions for referral into the Improving Access to Psychological Therapies (IAPT) integrated pathway. Local commissioning groups decide which pathways they integrate with based on their local prevalence and local intelligence data.</p><p> </p><p>Similarly, the NHS Digital IAPT dataset does not collect information on patients with a diagnosis of cancer, or types of cancer.</p><p> </p><p>There are currently no national plans to assess the effectiveness of the IAPT long-term health conditions pathway on people affected specifically by blood cancer. However there is robust evidence that by using the National Institute for Health and Care Excellence approved psychological therapies in addressing the mental health issues of those people with long term conditions earlier, talking therapies help to improve patients’ health outcomes so that they become less reliant on primary and emergency care and importantly, help patients to self-manage their long-term conditions more confidently.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN
150003 more like this
150004 more like this
question first answered
less than 2018-06-12T13:56:50.323Zmore like thismore than 2018-06-12T13:56:50.323Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917377
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans NHS Digital has to publish information on the types of cancer referred into the Improving Access to Psychological Therapies (IAPT) pathway for people with long-term health conditions in the statistical releases entitled, Psychological therapies: reports on the use of IAPT services. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150003 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>NHS England has not specified estimates of individual conditions for referral into the Improving Access to Psychological Therapies (IAPT) integrated pathway. Local commissioning groups decide which pathways they integrate with based on their local prevalence and local intelligence data.</p><p> </p><p>Similarly, the NHS Digital IAPT dataset does not collect information on patients with a diagnosis of cancer, or types of cancer.</p><p> </p><p>There are currently no national plans to assess the effectiveness of the IAPT long-term health conditions pathway on people affected specifically by blood cancer. However there is robust evidence that by using the National Institute for Health and Care Excellence approved psychological therapies in addressing the mental health issues of those people with long term conditions earlier, talking therapies help to improve patients’ health outcomes so that they become less reliant on primary and emergency care and importantly, help patients to self-manage their long-term conditions more confidently.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN
150002 more like this
150004 more like this
question first answered
less than 2018-06-12T13:56:50.37Zmore like thismore than 2018-06-12T13:56:50.37Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917378
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care what plans he has to make an assessment of the effectiveness of the Improving Access to Psychological Therapies pathway for people with long-term health conditions for people affected by blood cancer. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150004 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>NHS England has not specified estimates of individual conditions for referral into the Improving Access to Psychological Therapies (IAPT) integrated pathway. Local commissioning groups decide which pathways they integrate with based on their local prevalence and local intelligence data.</p><p> </p><p>Similarly, the NHS Digital IAPT dataset does not collect information on patients with a diagnosis of cancer, or types of cancer.</p><p> </p><p>There are currently no national plans to assess the effectiveness of the IAPT long-term health conditions pathway on people affected specifically by blood cancer. However there is robust evidence that by using the National Institute for Health and Care Excellence approved psychological therapies in addressing the mental health issues of those people with long term conditions earlier, talking therapies help to improve patients’ health outcomes so that they become less reliant on primary and emergency care and importantly, help patients to self-manage their long-term conditions more confidently.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN
150002 more like this
150003 more like this
question first answered
less than 2018-06-12T13:56:50.417Zmore like thismore than 2018-06-12T13:56:50.417Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917379
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the General Practice Forward View, what estimate he has made of the number of people with blood cancer that will have access to the 3,000 mental health therapists co-located in GP surgeries; and whether those therapists will be provided with specific training on blood cancer. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150005 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>No such estimate has been made. Mental health therapists are not specifically trained on blood cancer as a condition, however cancer as a general condition forms part of the training which aims to enable experienced psychological well-being practitioners and high intensity therapists to deliver National Institute for Health and Care Excellence recommended treatments for people presenting to Improving Access to Psychological Therapies services with long-term physical conditions such as diabetes, cardiac disease, respiratory disease, and cancer with accompanying low mood and/or anxiety. The training focuses on high intensity and low intensity approaches to support people with mental health problems and physical long-term conditions or persistent and distressing medically unexplained symptoms.</p> more like this
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
question first answered
less than 2018-06-12T15:23:42.813Zmore like thismore than 2018-06-12T15:23:42.813Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917380
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether access to psychological support under the Cancer Recovery Package will be provided through the Improving Access to Psychological Therapies pathway for people with long-term physical health conditions. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150006 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>Psychological support for cancer is a specialised area and is often offered within cancer teams via health psychology teams. Adults experiencing all forms of cancer are able to access Improving Access to Psychological Therapies services which provide evidence-based psychological therapies for people with anxiety disorders and depression. Recovery Package interventions will help ensure patients have more personal care and support from the point they are diagnosed. Two of the key interventions within the Recovery Package, the Health Needs Assessment and Care Plans, will enable patients to be sign-posted or referred to psychological support, where necessary.</p><p> </p><p>Personalised follow up and support to help people live well with and beyond cancer is one of the key strategic priorities in the Cancer Strategy for England, which aims to create world class cancer services. NHS England will roll out Recovery Package interventions nationally by 2020 so they are available to all cancer patients across the country regardless of location. All Cancer Alliances are receiving funding in 2018/19 to support implementation of the Recovery Package.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN 150008 more like this
question first answered
less than 2018-06-12T15:19:16.073Zmore like thismore than 2018-06-12T15:19:16.073Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917381
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ibrutinib more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care how many people have received Ibrutinib on the NHS for the treatment of relapsed or refractory chronic lymphocytic leukaemia since January 2017. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150007 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-13more like thismore than 2018-06-13
answer text <p>The information requested is not available. The number of patients registered to receive treatment with ibrutinib for relapsed or refractory chronic lymphocytic leukaemia between 1 January 2017 and 31 May 2018 was 976. Patients registered to receive a treatment do not then necessarily go on to receive treatment with a drug.</p> more like this
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
question first answered
less than 2018-06-13T15:32:47.153Zmore like thismore than 2018-06-13T15:32:47.153Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
917382
registered interest false more like this
date less than 2018-06-05more like thismore than 2018-06-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, which Cancer Alliances Groups are providing the cancer recovery package; and whether it is being provided to all people diagnosed with cancer in those areas. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 150008 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-06-12more like thismore than 2018-06-12
answer text <p>Psychological support for cancer is a specialised area and is often offered within cancer teams via health psychology teams. Adults experiencing all forms of cancer are able to access Improving Access to Psychological Therapies services which provide evidence-based psychological therapies for people with anxiety disorders and depression. Recovery Package interventions will help ensure patients have more personal care and support from the point they are diagnosed. Two of the key interventions within the Recovery Package, the Health Needs Assessment and Care Plans, will enable patients to be sign-posted or referred to psychological support, where necessary.</p><p> </p><p>Personalised follow up and support to help people live well with and beyond cancer is one of the key strategic priorities in the Cancer Strategy for England, which aims to create world class cancer services. NHS England will roll out Recovery Package interventions nationally by 2020 so they are available to all cancer patients across the country regardless of location. All Cancer Alliances are receiving funding in 2018/19 to support implementation of the Recovery Package.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN 150006 more like this
question first answered
less than 2018-06-12T15:19:16.12Zmore like thismore than 2018-06-12T15:19:16.12Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
904118
registered interest false more like this
date less than 2018-05-14more like thismore than 2018-05-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ibrutinib more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the interpretation by NHS England of NICE guidance on the level of provision of Ibrutinib for patients with chronic lymphocytic leukaemia. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 143739 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-05-21more like thismore than 2018-05-21
answer text <p>The National Institute for Health and Care Excellence (NICE) published guidance recommending ibrutinib for use in the treatment of previously treated chronic lymphocytic leukaemia and previously untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation in January 2017. NHS England is legally required to fund drugs and treatments recommended in NICE technology appraisal guidance in line with NICE’s recommendations.</p><p> </p><p>NICE has not been able to make a recommendation on the use of ibrutinib for use in the treatment of other patients with chronic lymphocytic leukaemia because no evidence submission was received from the product’s manufacturer. Ibrutinib is not therefore routinely commissioned for National Health Service patients for these other indications. NICE will review this decision if the company decides to make an evidence submission.</p> more like this
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
grouped question UIN 144154 more like this
question first answered
less than 2018-05-21T15:59:46.487Zmore like thismore than 2018-05-21T15:59:46.487Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
896505
registered interest false more like this
date less than 2018-05-02more like thismore than 2018-05-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure people with blood cancer are diagnosed as soon as possible. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 140696 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-05-14more like thismore than 2018-05-14
answer text <p>Early diagnosis of blood cancers is difficult as symptoms, such as tiredness or back pain, are often misdiagnosed. For suspected blood cancers, the National Institute for Health and Care Excellence published a revised guideline in 2015 which clearly sets out that general practitioners should consider a very urgent full blood count within 48 hours to assess for leukaemia if adults present with suspicious symptoms.</p><p> </p><p>In December 2016 NHS England announced transformation funding of £200 million for Cancer Alliances to encourage new and innovative ways to diagnose cancer earlier, improve the care for those living with cancer and ensure that each cancer patient gets the right care for them.</p><p> </p><p>Additionally, the Accelerate, Coordinate and Evaluate Programme is a unique early diagnosis initiative, a programme of 60 projects exploring innovative concepts of diagnosing cancer earlier across England. The programme is testing a new multi-disciplinary diagnostic centre approach to diagnosing patients with vague or unclear but concerning symptoms, often characteristic of hard to diagnose cancers like blood cancers.</p>
answering member constituency Winchester remove filter
answering member printed Steve Brine more like this
question first answered
less than 2018-05-14T11:23:24.86Zmore like thismore than 2018-05-14T11:23:24.86Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this